FI834424L - Monoklonala antikroppar vilka reagerar med gemensamma idiotyper hos maenniskans antikroppar mot nativt dna fraon patienten med systemisk lupus erythematosus. - Google Patents

Monoklonala antikroppar vilka reagerar med gemensamma idiotyper hos maenniskans antikroppar mot nativt dna fraon patienten med systemisk lupus erythematosus. Download PDF

Info

Publication number
FI834424L
FI834424L FI834424A FI834424A FI834424L FI 834424 L FI834424 L FI 834424L FI 834424 A FI834424 A FI 834424A FI 834424 A FI834424 A FI 834424A FI 834424 L FI834424 L FI 834424L
Authority
FI
Finland
Prior art keywords
med
antikroppar
systemisk
reagerar
nativt
Prior art date
Application number
FI834424A
Other languages
English (en)
Finnish (fi)
Other versions
FI834424A7 (fi
FI834424A0 (fi
Inventor
Betty Ann Diamond
Original Assignee
Univ Yeshiva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yeshiva filed Critical Univ Yeshiva
Priority to FI902365A priority Critical patent/FI902365A7/fi
Publication of FI834424A0 publication Critical patent/FI834424A0/fi
Publication of FI834424A7 publication Critical patent/FI834424A7/fi
Publication of FI834424L publication Critical patent/FI834424L/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/686Anti-idiotype
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104Lupus erythematosus [SLE]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/824Immunological separation techniques
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813Carrier is a saccharide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI834424A 1982-12-03 1983-12-02 Monoklonala antikroppar vilka reagerar med gemensamma idiotyper hos maenniskans antikroppar mot nativt dna fraon patienten med systemisk lupus erythematosus. FI834424L (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI902365A FI902365A7 (fi) 1982-12-03 1983-12-02 Hybridooma, joka erittää vasta-aineita, jotka reagoivat systeemistä lupus erythematosusta sairastavien potilaiden luontaisen DNA:n vastaisissa vasta-aineissa esiintyvien, näille potilaille yhteisen idiotyypin kanssa

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44671882A 1982-12-03 1982-12-03
US06/552,290 US4692416A (en) 1982-12-03 1983-11-16 Monoclonal antibodies reactive with shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus

Publications (3)

Publication Number Publication Date
FI834424A0 FI834424A0 (fi) 1983-12-02
FI834424A7 FI834424A7 (fi) 1984-06-04
FI834424L true FI834424L (fi) 1984-06-04

Family

ID=27034715

Family Applications (1)

Application Number Title Priority Date Filing Date
FI834424A FI834424L (fi) 1982-12-03 1983-12-02 Monoklonala antikroppar vilka reagerar med gemensamma idiotyper hos maenniskans antikroppar mot nativt dna fraon patienten med systemisk lupus erythematosus.

Country Status (11)

Country Link
US (1) US4692416A (fr)
EP (1) EP0113431B1 (fr)
AU (1) AU566246B2 (fr)
CA (1) CA1215009A (fr)
DE (1) DE3382009D1 (fr)
DK (1) DK557383A (fr)
ES (1) ES8607024A1 (fr)
FI (1) FI834424L (fr)
IL (1) IL70366A (fr)
NO (1) NO163039C (fr)
NZ (1) NZ206467A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536479A (en) * 1983-03-22 1985-08-20 E. I. Du Pont De Nemours And Company Use of anti-idiotype antibodies in immunoassays
ATE45285T1 (de) * 1983-11-07 1989-08-15 Wistar Inst Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren.
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
JPS61205862A (ja) * 1985-03-08 1986-09-12 Shionogi & Co Ltd アレルゲン特異IgG抗体測定用試薬
US4865970A (en) * 1986-02-28 1989-09-12 Hoffmann-La Roche Inc. Method of detecting ribosomal protein antibodies in systemic lupus erythematosus
DE3609271A1 (de) * 1986-03-19 1987-09-24 Boehringer Mannheim Gmbh Verfahren und reagenz zum nachweis von autoimmunerkrankungen, arzneimittel zur behandlung von autoimmunerkrankungen sowie hierzu geeignete antiparatypische antikoerper
WO1988007058A1 (fr) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anticorps antiparatopique servant d'immunogene
US5428132A (en) * 1987-10-11 1995-06-27 United States Of America Conjugate and method for integration of foreign DNA into cells
PT89107A (pt) * 1987-11-30 1989-11-30 Idec Pharma Corp Metodo e meios para a seleccao de anticorpos anti-idiotipos e seu uso para o diagnostico, monitorizacao, tratamento e/ou prevencao de doencas cancerosas, da autoimunidade ou infecciosas
US6232444B1 (en) 1990-01-29 2001-05-15 The Regents Of The University Of California Conserved anti-DNA antibody idiotype associated with nephritis in murine and human lupus
AU8083591A (en) * 1990-06-08 1991-12-31 Symbicom Aktiebolag Therapy and prophylaxis of autoimmune diseases
US7888458B1 (en) 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
AU7349496A (en) * 1995-05-25 1996-12-11 Oklahoma Medical Research Foundation Method for treatment of SLE
US7273613B1 (en) 1997-01-13 2007-09-25 The Board of Regents, The University of Oklahoma Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
TWI434855B (zh) * 2006-11-21 2014-04-21 Hoffmann La Roche 結合物及其在免疫分析中作為參考標準之用途
WO2009014476A1 (fr) * 2007-07-24 2009-01-29 Iss Immune System Stimulation Ab Procédé et moyen de prédiction d'une sensibilité systémique au lupus erythematosus
US8283408B2 (en) 2010-02-26 2012-10-09 Hexcel Corporation Thermoplastic-toughened cyanate ester resin composites with low heat release properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234563A (en) * 1978-06-02 1980-11-18 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4493899A (en) * 1981-10-16 1985-01-15 City Of Hope Method of testing for particular antibodies in the serum of a patient
DE3364347D1 (en) * 1982-04-09 1986-08-07 Fujirebio Kk Anti immune complex antibody and preparation thereof
US4487830A (en) * 1982-05-14 1984-12-11 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies

Also Published As

Publication number Publication date
ES8607024A1 (es) 1986-06-16
FI834424A7 (fi) 1984-06-04
EP0113431A2 (fr) 1984-07-18
AU566246B2 (en) 1987-10-15
ES527730A0 (es) 1986-06-16
DK557383D0 (da) 1983-12-02
DK557383A (da) 1984-06-04
NO834434L (no) 1984-06-04
FI834424A0 (fi) 1983-12-02
EP0113431B1 (fr) 1990-11-22
EP0113431A3 (en) 1986-08-27
NO163039B (no) 1989-12-11
US4692416A (en) 1987-09-08
DE3382009D1 (de) 1991-01-03
CA1215009A (fr) 1986-12-09
IL70366A (en) 1987-11-30
AU2171283A (en) 1984-06-07
IL70366A0 (en) 1984-03-30
NZ206467A (en) 1986-11-12
NO163039C (no) 1990-03-21

Similar Documents

Publication Publication Date Title
FI73523B (fi) Tryck- eller tryckdifferensmaetare med en mot oeverbelastning skyddad tryckavkaenningsanordning.
FI834326L (fi) Engaongsbloeja med elastiskt hopdragbart midjeband.
FI834747A7 (fi) Kationfoereningar innehaollande tvaettmedelskompositioner med lersmuts avlaegsnings-/aoterutfaellning foerhindrande egenskaper.
FI841522A7 (fi) Processtyrsystem med felsoekning.
FI834361L (fi) Teledatasystem med publikterminaler.
FI834199A7 (fi) Med sjaelvdraeneringsanordning foersedd dispenserings- och maetningsfoerpackning foer en vaetskeprodukt.
DE3381065D1 (de) Universelle interface-einheit.
NO158972C (no) Styrespakanordning.
FI841571A7 (fi) Gummiartiklar framstaellda genom doppning.
ES279046Y (es) Soporte de carga.
NO823851L (no) Koblingslist.
FI834718L (fi) Staellningssystem.
FI834424L (fi) Monoklonala antikroppar vilka reagerar med gemensamma idiotyper hos maenniskans antikroppar mot nativt dna fraon patienten med systemisk lupus erythematosus.
FI842049A7 (fi) Taetningsanordning mellan roerliga delar.
IT1210489B (it) Benzossazine antipsicotiche.
FI842821A0 (fi) System foer golvlaeggning.
FI834693L (fi) Tryckanordning med elektrostatisk tryckhjaelp.
FI834311L (fi) Med samlingsroer foersedd sz- tvinnmaskin.
FI842715A0 (fi) Temperatur/tidsgraensindikator.
FI834606L (fi) Elektrisk tryckknoppkoppling med en vridbart lagrad tryckbaoge.
FI834474L (fi) Cyklonavskiljare med filterenhet.
FI834327A7 (fi) Draeneringsanordning med avboejd gasstroemningsvaeg.
NO162118C (no) Begroingshindrende belegningsmiddel.
FI834401L (fi) Fenotiazinfoereningar.
ES271352Y (es) Dispositivo de conexion.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: YESHIVA UNIVERSITY